| 2005 | First Outbreak of Klebsiella pneumoniae Clinical Isolates Producing GES-5 and SHV-12 Extended-Spectrum β-Lactamases in Korea
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2017 | First report of blaOXA-499 as a carbapenemase 1 gene from Acinetobacter pittii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2012 | Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, bla AIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2003 | Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2003 | High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2020 | Impact of vanA-Positive Enterococcus faecium Exhibiting Diverse Susceptibility Phenotypes to Glycopeptides on 30-Day Mortality of Patients with a Bloodstream Infection | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2007 | In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2009 | In vitro activities of panduratin A against clinical Staphylococcus strains
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2006 | Increasing Prevalence and Diversity of Metallo-β-Lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2011 | Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2011 | Metallo-beta-lactamase production by Pseudomonas otitidis: a species-related trait.
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2005 | Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1
Integron from Acinetobacter baumannii Clinical Isolates
from Korea
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2010 | Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2019 | Prospective Observational Study of the Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2020 | Reply to Cabrera et al., "Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results"
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2019 | Reply to Zhou and Tang, “Some Doubts on the Study of Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis” | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2016 | Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2019 | Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
